Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
The article describes a clinical case of a progressive form of systemic scleroderma in a 39-year-old man. The patient has an acute course and rapid progression of the disease with a significant initial decrease in the forced vital capacity of the lungs, with signs of an unfavorable prognosis, such a...
Main Authors: | E. N. Harlamova, Ju. Ju. Karpenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2021-01-01
|
Series: | Arhivʺ Vnutrennej Mediciny |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/1123 |
Similar Items
-
EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01) -
RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01) -
Effect of rituximab on heart involvement in systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2019-01-01) -
A case of sine scleroderma with parenchymal lung disease
by: Mansoor Karimifar, et al.
Published: (2014-01-01) -
Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab
by: L. P. Ananieva, et al.
Published: (2020-09-01)